Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.

ABSTRACT:

Background

In the Systolic Blood Pressure Intervention Trial (SPRINT), adults at high risk for cardiovascular disease who received intensive systolic blood-pressure control (target, <120 mm Hg) had significantly lower rates of death and cardiovascular disease events than did those who received standard control (target, <140 mm Hg). On the basis of these data, we wanted to determine the lifetime health benefits and health care costs associated with intensive control versus standard control.

Methods

We used a microsimulation model to apply SPRINT treatment effects and health care costs from national sources to a hypothetical cohort of SPRINT-eligible adults. The model projected lifetime costs of treatment and monitoring in patients with hypertension, cardiovascular disease eve

SUBMITTER: Bress AP 

PROVIDER: S-EPMC5708850 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature